Biotechnology, clinical stage, CNC, autoimmune, fibrotic indications
Graviton Bioscience has raised $25.0M in total funding. The most recent round was Private Equity. The last funding was announced in January 2024.
Graviton Bioscience's investors include Sanofi, Enavate Sciences, Pontifax.
Graviton Bioscience is headquartered in New York, United States.
Biotechnology, clinical stage, CNC, autoimmune, fibrotic indications
Graviton Bioscience is at the Private Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Graviton Bioscience — Funding & Investors." VCBacked, January 2, 2024, https://www.vcbacked.co/company/graviton-bioscience. Accessed August 14, 2026.
VCBacked. (2024). Graviton Bioscience — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/graviton-bioscience
{{cite web |title=Graviton Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/graviton-bioscience |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated